|Articles|January 19, 2023
Leveraging efficiency from cell line development to clinical manufacturing of monoclonal antibodies
Author(s)Curia
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
2
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
3
Novartis Calls for Global Governments to Address Global Trade Policy
4